Amedeo Smart

Free Medical Literature Service

 

Amedeo

Anemia
  Free Subscription

Articles published in
Int J Hematol
    January 2026
  1. KAYA H, Hamada M, Murayama Y, Mochizuki K, et al
    Micafungin-induced hemolytic anemia: a case report and investigation of anti-micafungin antibody prevalence.
    Int J Hematol. 2026 Jan 28. doi: 10.1007/s12185-026-04161.
    >> Share

    December 2025
  2. BASAK B, Biswas P, Dey S, Paul A, et al
    Iron deficiency anemia perturbs erythrocyte morphology and may promote eryptosis.
    Int J Hematol. 2025 Dec 4. doi: 10.1007/s12185-025-04126.
    >> Share

    November 2025
  3. KOMATSU N, Ito K, Arita K, Mitobe Y, et al
    Effect of food on iron absorption in patients with iron deficiency anemia treated with ferric citrate hydrate.
    Int J Hematol. 2025 Nov 14. doi: 10.1007/s12185-025-04108.
    >> Share

  4. MANGANAS K, Delicou S, Hadziyannis E, Giannouli S, et al
    Growth differentiation factor-15 as a non-invasive biomarker of liver fibrosis in sickle cell disease.
    Int J Hematol. 2025;122:637-646.
    >> Share

    September 2025
  5. ASWAD HA, Haleem AA, Eissaa AA
    Late renal, liver, endocrine, and cardiac outcomes of bone marrow transplantation in Kurdish children with beta-thalassemia major.
    Int J Hematol. 2025 Sep 19. doi: 10.1007/s12185-025-04067.
    >> Share

    August 2025
  6. GROVER P, S A
    Efficacy of alternate day versus daily oral iron therapy in children with iron deficiency anemia: a randomized controlled trial.
    Int J Hematol. 2025 Aug 17. doi: 10.1007/s12185-025-04048.
    >> Share

    July 2025
  7. YOON SS, Chen CC, Lee SE, Chang H, et al
    Efficacy and safety of momelotinib in Janus kinase inhibitor-experienced Asian patients with myelofibrosis and anemia.
    Int J Hematol. 2025 Jul 21. doi: 10.1007/s12185-025-04037.
    >> Share

    June 2025
  8. IMASHUKU S, Kazuma Y, Chonabayashi K, Shimazu Y, et al
    Myelodysplastic syndrome with ring chromosomes in a case of dehydrated hereditary stomatocytosis 1 (DHS1).
    Int J Hematol. 2025;121:857-861.
    >> Share

    May 2025
  9. WANG X, Qin X, Luo C, Luo C, et al
    Early withdrawal immunosuppression improved mixed chimerism in stem cell transplantation for pediatric aplastic anemia.
    Int J Hematol. 2025 May 23. doi: 10.1007/s12185-025-03971.
    >> Share

    April 2025
  10. CHARITAKI E, Liapis K
    Spherocytic hemolytic anemia caused by Clostridium perfringens.
    Int J Hematol. 2025 Apr 15. doi: 10.1007/s12185-025-03993.
    >> Share

  11. TOKUSHIGE J, Taoka K, Nishikawa M, Jona M, et al
    Discovery of a second, distinct development pattern of leukemic conversion from paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2025;121:543-546.
    >> Share

  12. RAO M, Luo W, Wu B
    The medium-fluorescence reticulocyte ratio is an independent predictor of G6PD deficiency neonates.
    Int J Hematol. 2025;121:526-532.
    >> Share

    February 2025
  13. YAMAMOTO R, Hiramoto N, Nagai Y, Ishikawa T, et al
    Iron deficiency anemia following long-term eltrombopag treatment for aplastic anemia: a single-institution experience.
    Int J Hematol. 2025 Feb 12. doi: 10.1007/s12185-025-03940.
    >> Share

  14. MOMBO LE, Moreau BD, Bisseye C, Mikelet Boussoukou IP, et al
    Screening for sickle cell anemia in two populations of eastern Gabon using alkaline electrophoresis and hemoglobin level combined with leukocyte count.
    Int J Hematol. 2025 Feb 5. doi: 10.1007/s12185-025-03934.
    >> Share

    January 2025
  15. KOSUGI H, Fujisaki T, Iwasaki H, Shinagawa A, et al
    A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes.
    Int J Hematol. 2025;121:68-78.
    >> Share

  16. EDAHIRO Y, Komatsu N
    Iron deficiency and phlebotomy in patients with polycythemia vera.
    Int J Hematol. 2025;121:39-44.
    >> Share

    December 2024
  17. EGUCHI K, Ishimura M, Ohga S, Endo S, et al
    Adjunctive effects of eltrombopag on immunosuppressive therapy for childhood aplastic anemia.
    Int J Hematol. 2024 Dec 27. doi: 10.1007/s12185-024-03903.
    >> Share

  18. MOMOEDA M, Ito K, Inoue S, Shibahara H, et al
    Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia.
    Int J Hematol. 2024 Dec 26. doi: 10.1007/s12185-024-03905.
    >> Share

  19. MIYAKAWA Y, Sato E, Ogawa Y, Nishimura JI, et al
    Long-term safety profile of sutimlimab in adult Japanese patients with cold agglutinin disease.
    Int J Hematol. 2024;120:656-664.
    >> Share

  20. SATO K, Nakamura Y, Hara R, Kayama R, et al
    Adult-onset severe paroxysmal cold hemoglobinuria after COVID-19 successfully treated with sutimlimab.
    Int J Hematol. 2024;120:735-742.
    >> Share

    November 2024
  21. AL-JUBOURI AM, Eliwa A, Haithm Y, Al-Qahtani N, et al
    Relationship between hemoglobinopathies and male infertility: a scoping review.
    Int J Hematol. 2024;120:566-574.
    >> Share

    September 2024
  22. SAEIDNIA M, Shadfar F, Sharifi S, Babashahi M, et al
    Skin complications during iron chelation therapy for beta-thalassemia: overview and treatment approach.
    Int J Hematol. 2024;120:271-277.
    >> Share

    May 2024
  23. KOSUGI M, Takezawa R, Shiota S, Tsuchikawa M, et al
    Clinical management of iron deficiency anemia in Japan: iron prescription patterns, treatment effectiveness, and assessments.
    Int J Hematol. 2024 May 28. doi: 10.1007/s12185-024-03801.
    >> Share

    April 2024
  24. WU LS, Luo X, Tan M, Zhang LJ, et al
    Prevalence of thalassemia-carrier couples and fertility risk assessment.
    Int J Hematol. 2024;119:374-382.
    >> Share

    March 2024
  25. SAWADA Y, Sakamoto K, Tsukamura A, Sawai C, et al
    Vitamin B12 deficiency-induced megaloblastic anemia in a pediatric patient with autism spectrum disorder with a chronically unbalanced diet.
    Int J Hematol. 2024 Mar 25. doi: 10.1007/s12185-024-03759.
    >> Share

  26. KOMATSU N, Arita K, Mitsui H, Nemoto T, et al
    Correction: Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
    Int J Hematol. 2024 Mar 6. doi: 10.1007/s12185-024-03739.
    >> Share

  27. OBARA N, Usuki K, Hayashi T, Fujii M, et al
    Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors.
    Int J Hematol. 2024;119:255-264.
    >> Share

  28. NAKAO S
    Diagnosis of immune pathophysiology in patients with bone marrow failure.
    Int J Hematol. 2024;119:231-239.
    >> Share

    February 2024
  29. SCHEINBERG P
    Progress in medical therapy in aplastic anemia: why it took so long?
    Int J Hematol. 2024 Feb 26. doi: 10.1007/s12185-024-03713.
    >> Share

  30. ONISHI Y
    Aplastic anemia: history and recent developments in diagnosis and treatment.
    Int J Hematol. 2024 Feb 4. doi: 10.1007/s12185-024-03715.
    >> Share

    January 2024
  31. IGUCHI A, Uchiyama T, Fujimori K, Gocho Y, et al
    HLA-haploidentical T-cell receptor alphabetaT/B-cell-depleted stem cell transplantation for Fanconi anemia.
    Int J Hematol. 2024 Jan 16. doi: 10.1007/s12185-023-03703.
    >> Share

  32. KASHIWAGI H, Kuwana M, Murata M, Shimada N, et al
    Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.
    Int J Hematol. 2024;119:1-13.
    >> Share

    December 2023
  33. MAKITA S, Ota S, Mishima Y, Usuki K, et al
    Japanese phase Ib study of the oral PI3K-delta and -gamma inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Int J Hematol. 2023 Dec 27. doi: 10.1007/s12185-023-03689.
    >> Share

  34. ZHENG J, Gao L, Liu H, Xiao P, et al
    Congenital dyserythropoietic anemia type II in a newborn with a novel compound heterozygous mutation in the SEC23B: a case report and review of the literature.
    Int J Hematol. 2023 Dec 21. doi: 10.1007/s12185-023-03676.
    >> Share

  35. MIKI K, Ogasawara R, Sugimura S, Sugita J, et al
    A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation.
    Int J Hematol. 2023;118:766-771.
    >> Share

    October 2023
  36. SHINN LT, Benitez LL, Perissinotti AJ, Reid JH, et al
    Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia.
    Int J Hematol. 2023 Oct 26. doi: 10.1007/s12185-023-03670.
    >> Share

  37. FUKATSU M, Hamazaki Y, Sato Y, Koyama D, et al
    A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and KMT2D.
    Int J Hematol. 2023;118:472-476.
    >> Share

  38. NISHIMURA JI, Kawaguchi T, Ito S, Murai H, et al
    Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan.
    Int J Hematol. 2023;118:419-431.
    >> Share

    September 2023
  39. CHATZIKALIL E, Kattamis A, Diamantopoulos P, Solomou EE, et al
    New-onset aplastic anemia after SARS-CoV-2 vaccination.
    Int J Hematol. 2023 Sep 28. doi: 10.1007/s12185-023-03666.
    >> Share

  40. LI H, Wang J, Wang D, Gan Y, et al
    Ten years' experience in prenatal diagnosis of alpha-thalassemia in a municipal hospital and retrospective analysis of ultrasonic abnormalities.
    Int J Hematol. 2023;118:355-363.
    >> Share

  41. USUKI K, Ikezoe T, Ishiyama K, Kanda Y, et al
    Interim analysis of post-marketing surveillance of ravulizumab for paroxysmal nocturnal hemoglobinuria in Japan.
    Int J Hematol. 2023;118:311-322.
    >> Share

  42. WANG P, Yang S
    Clonal cytopenia of undetermined significance presenting with multiple duplications of chromosome 1q.
    Int J Hematol. 2023;118:307-308.
    >> Share

    July 2023
  43. EDAHIRO Y, Ochiai T, Hashimoto Y, Morishita S, et al
    Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
    Int J Hematol. 2023;118:47-53.
    >> Share

    May 2023
  44. KOBAYASHI M, Mori A, Oda Y, Yokoyama E, et al
    New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination.
    Int J Hematol. 2023 May 23:1-6. doi: 10.1007/s12185-023-03618.
    >> Share

    April 2023
  45. SALES RR, Luizon MR
    Effect of haplotypes of functional SNPs related to expression of fetal hemoglobin (HbF) on clinical prognosis of hematological malignancies.
    Int J Hematol. 2023;117:626-627.
    >> Share

  46. YAMANO S, Iguchi A, Ishikawa K, Sakamoto A, et al
    Splenectomy as an effective treatment for macrothrombocytopenia in Takenouchi-Kosaki syndrome.
    Int J Hematol. 2023;117:622-625.
    >> Share

  47. SUZUKI Y, Shiba T
    Chronic cold agglutinin disease after a third COVID-19 mRNA vaccination.
    Int J Hematol. 2023;117:618-621.
    >> Share

    March 2023
  48. YOSHIDA N
    Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia.
    Int J Hematol. 2023 Mar 3. doi: 10.1007/s12185-023-03564.
    >> Share

  49. KUBO M, Matsumoto M
    Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura.
    Int J Hematol. 2023;117:331-340.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016